Does Oseltamivir Really Reduce Complications of Influenza?

Does Oseltamivir Really Reduce Complications of Influenza?

Bibliographic Details
Main Authors:	Del Mar, C, Doshi, P, Hama, R, Heneghan, C, Jefferson, T, Jones, M, Thompson, M, Inhibitors, C
Format:	Journal article
Published:	2011

Similar Items

Neuraminidase inhibitors for influenza complications.
by: Del Mar, C, et al.
Published: (2014)

Risk of bias in industry-funded oseltamivir trials: comparison of core reports versus full clinical study reports
by: Jefferson, T, et al.
Published: (2014)

Oseltamivir for influenza in adults and children: systematic review of clinical study reports and summary of regulatory comments.
by: Jefferson, T, et al.
Published: (2014)

Oseltamivir and influenza-related complications in children: a retrospective cohort in primary care
by: Lee, J, et al.
Published: (2020)

Antivirals for treatment of influenza.
by: Heneghan, C, et al.
Published: (2012)

Neuraminidase inhibitors for influenza: a systematic review and meta-analysis of regulatory and mortality data.
by: Heneghan, C, et al.
Published: (2016)

Neuraminidase inhibitors for influenza: a systematic review and meta-analysis of regulatory and mortality data
by: Heneghan, C, et al.
Published: (2016)

Neuraminidase inhibitors for preventing and treating influenza in healthy adults and children.
by: Jefferson, T, et al.
Published: (2014)

Neuraminidase inhibitors for preventing and treating influenza in healthy adults and children
by: Jefferson, T, et al.
Published: (2014)

Combination therapy of nitazoxanide with oseltamivir compared with oseltamivir in hospitalized patients with seasonal influenza
by: Parvaiz A Koul, et al.
Published: (2024-01-01)

Debate Regarding Oseltamivir Use for Seasonal and Pandemic Influenza
by: Aeron C. Hurt, et al.
Published: (2016-06-01)

Comparative effectiveness of combined favipiravir and oseltamivir therapy versus oseltamivir monotherapy in critically ill patients with influenza virus infection
by: Wang, Y, et al.
Published: (2019)

Inhibition of Influenza Virus Replication by Oseltamivir Derivatives
by: Renee W. Y. Chan, et al.
Published: (2022-02-01)

Antivirals for treatment of influenza.
by: Jones, M, et al.
Published: (2012)

Efficacy of oseltamivir treatment in influenza virus-infected obese mice
by: Rebekah Honce, et al.
Published: (2023-08-01)

Antiviral Activity of Probenecid and Oseltamivir on Influenza Virus Replication
by: Jackelyn Murray, et al.
Published: (2023-11-01)

Combination therapy with amantadine, oseltamivir and ribavirin for influenza A infection: safety and pharmacokinetics.
by: Seo, S, et al.
Published: (2013)

THE CLINICAL AND LABORATORY EFFECTIVENESS OF OSELTAMIVIR FOR TREATMENT OF INFLUENZA IN HOSPITALIZED PATIENTS
by: L. V. Voloschcuk, et al.
Published: (2015-06-01)

Acute Cheilitis Associated with Oseltamivir after Influenzae A Infection
by: Koji Yokoyama, et al.
Published: (2023-01-01)

Interferon Lambda Delays the Emergence of Influenza Virus Resistance to Oseltamivir
by: Chiara Medaglia, et al.
Published: (2021-06-01)

Neuraminidase inhibitors for preventing and treating influenza in healthy adults: systematic review and meta-analysis
by: Doshi, Peter, et al.
Published: (2009)

Ensuring safe and effective drugs: who can do what it takes?
by: Jefferson, T, et al.
Published: (2011)

Population pharmacokinetics of oseltamivir and oseltamivir carboxylate in obese and Non-obese volunteers.
by: Chairat, K, et al.
Published: (2016)

Ensuring safe and effective drugs: who can do what it takes?
by: Jefferson, T, et al.
Published: (2011)

Comparison of oseltamivir and α-galactosylceramide for reducing disease and transmission in pigs infected with 2009 H1N1 pandemic influenza virus
by: Darling Melany de C. Madrid, et al.
Published: (2022-10-01)

Zanamivir for influenza in adults and children: systematic review of clinical study reports and summary of regulatory comments.
by: Heneghan, C, et al.
Published: (2014)

Oseltamivir resistance in influenza A (H5N1) infection - Reply
by: Jong, d, et al.
Published: (2006)

Oseltamivir-resistant h1n1 influenza virus: case report
by: Mohammad Danyal Kayani
Published: (2022-09-01)

Oseltamivir resistance during treatment of influenza A (H5N1) infection.
by: Jong, d, et al.
Published: (2005)

Oseltamivir compounding in the hospital pharmacy during the (H1N1) influenza pandemic
by: Márcia Lúcia de Mário Marin, et al.
Published: (2010-01-01)

A community cluster of oseltamivir-resistant cases of 2009 H1N1 influenza.
by: Le, Q, et al.
Published: (2010)

A community cluster of oseltamivir-resistant cases of 2009 H1N1 influenza
by: Mai, L, et al.
Published: (2010)

Plasma concentrations of oseltamivir and oseltamivir carboxylate in critically ill children on extracorporeal membrane oxygenation support.
by: Enno D Wildschut, et al.
Published: (2010-01-01)

Antivirals for pandemic influenza: a triumph of policy over evidence?
by: Thompson, M, et al.
Published: (2010)

Antivirals for pandemic influenza: a triumph of policy over evidence?
by: Thompson, M, et al.
Published: (2010)

Impact of oseltamivir on the risk of cancer
by: Pei-Hua Chuang, et al.
Published: (2024-02-01)

Comparison of oseltamivir and oseltamivir carboxylate concentrations in venous plasma, venous blood, and capillary blood in healthy volunteers.
by: Instiaty, I, et al.
Published: (2013)

Pharmacokinetics of high-dose oseltamivir in healthy volunteers.
by: Wattanagoon, Y, et al.
Published: (2009)

Discovery of Novel Boron-Containing <em>N</em>-Substituted Oseltamivir Derivatives as Anti-Influenza A Virus Agents for Overcoming N1-H274Y Oseltamivir-Resistant
by: Ruifang Jia, et al.
Published: (2022-09-01)

Glycemic variability: Measurement, target, impact on complications of diabetes and does it really matter?
by: Yifei Mo, et al.
Published: (2024-01-01)